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tTATE-OF-THE-ART PAPER9The Aging Heart and Post-Infarction Left Ventricular Remodelingenry Shih, Brian Lee, Randall J. Lee, Andrew J. Boyle
hih and colleagues review the clinical and experimental data on how aging affects the heart,
articularly the fact that elderly patients are more likely to develop heart failure following a
yocardial infarction. The progressive accumulation of metabolic waste and damaged
rganelles in cardiomyocytes inhibits autophagy and increases the cell’s propensity toward
poptosis. Also, elderly patients have decreased cardiomyocyte renewal capacity, which limits
he ability of the heart to respond to stress.CLINICAL RESEARCH NTERVENTIONAL CARDIOLOGY
18erebral Embolism Following TAVI:
No Difference Between Transfemoral and Transapical Approachesosep Rodés-Cabau, Eric Dumont, Robert H. Boone, Eric Larose, Rodrigo Bagur, Ronen Gurvitch,
ernand Bédard, Daniel Doyle, Robert De Larochellière, Cleonie Jayasuria, Jacques Villeneuve,
lier Marrero, Mélanie Côté, Philippe Pibarot, John G. Webb
odés-Cabau and colleagues compared the incidence of cerebral embolism detected by
iffusion-weighted magnetic resonance imaging (DW-MRI) following transapical (TA)
ranscatheter aortic valve implantation (TAVI) compared with transfemoral (TF) TAVI. A
otal of 68% of all subjects had at least 1 new lesion detected by DW-MRI after the
rocedure, with no difference in lesion number or size between the TF and TA groups.
AVI is associated with a high rate of asymptomatic cerebral ischemic lesions, but the TA
pproach, which avoids large catheter manipulation in the ascending aorta, does not reduce
his risk.(continued on page A-20)
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ECUTE MYOCARDIAL INFARCTION29Glucose, eGFR, and NT-proBNP Predict Mortality in STEMI Patients50
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High
No. at risk
178                        131                        108                          34   
196                        180                        149                          51
660                        644                        562                        220
Interm
Low
 P<0.001eter Damman, Marcel A. M. Beijk, Wichert J. Kuijt, Niels J. W. Verouden, Nan van Geloven,
osé P. S. Henriques, Jan Baan, Marije M. Vis, Martijn Meuwissen, Jan P. van Straalen, Johan Fischer,
arel T. Koch, Jan J. Piek, Jan G. P. Tijssen, Robbert J. de Winter
amman and colleagues used data from ST-segment elevation myocardial infarction
STEMI) patients undergoing primary percutaneous coronary intervention to investigate
redictors of subsequent mortality. In Cox regression, glucose, estimated glomerular filtration
ate (eGFR), and N-terminal pro-brain natriuretic peptide (NT-proBNP) on presentation
ere predictors for mortality. A risk score incorporating these 3 biomarkers was devised: those
atients with a score 6 had a 42% chance of dying compared with only 5.8% for those with
score 4. This simple calculation with commonly obtained biomarkers can improve the
rediction of mortality in STEMI patients.ditorial Comment: Luigi M. Biasucci, Roberta Della Bona, p. 37EART RHYTHM DISORDERS40Copy Number Variation Identifies Mutations in LQTS Patientsulien Barc, François Briec, Sébastien Schmitt, Florence Kyndt, Martine Le Cunff, Estelle Baron, Claude Vieyres,
rédéric Sacher, Richard Redon, Cédric Le Caignec, Hervé Le Marec, Vincent Probst, Jean-Jacques Schott
ecent studies have suggested that duplications or deletions of certain genes, also known as
opy number variants (CNVs), may underlie the genetic cause of long QT syndrome
LQTS). Typical genetic screening programs may not detect CNVs. Barc and colleagues
ssessed the frequency of CNVs in LQTS patients considered mutation-negative. Three
ifferent deletions were found in 3 unrelated families. This study demonstrates that CNVs in
CNQ1 and KCNH2 genes may be a relatively frequent cause of LQTS in patients with no
oint mutation in these genes.ditorial Comment: Stephen S. Rich, Ira M. Hall, p. 48EART RHYTHM DISORDERS51Risk of Cardiac Events in Patients With Genotype-Confirmed LQTS and a Normal QTclan Goldenberg, Samuel Horr, Arthur J. Moss, Coeli M. Lopes, Alon Barsheshet, Scott McNitt, Wojciech
areba, Mark L. Andrews, Jennifer L. Robinson, Emanuela H. Locati, Michael J. Ackerman, Jesaia Benhorin,
lizabeth S. Kaufman, Carlo Napolitano, Pyotr G. Platonov, Silvia G. Priori, Ming Qi, Peter J. Schwartz,
ataru Shimizu, Jeffrey A. Towbin, G. Michael Vincent, Arthur A. M. Wilde, Li Zhang
oldenberg and colleagues studied the risk of life-threatening events among long QT
yndrome (LQTS) patients with normal corrected QT intervals (QTc). The cumulative
robability of aborted cardiac arrest (ACA) or sudden cardiac death (SCD) before age 40
ears was 4% among patients with an LQTS mutation but a normal-range QTc compared
ith 15% for those with a prolonged QTc. The rate in unaffected family members was 0.4%.
hese results show that genotype-confirmed patients with concealed LQTS make up about
5% of the at-risk LQTS population.ditorial Comment: Dan M. Roden, p. 60
(continued on page A-21)
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63onlipid Biomarkers Do Not Predict Cardiovascular Outcomes in
Statin-Treated Patientsenoit J. Arsenault, Philip Barter, David A. DeMicco, Weihang Bao, Gregory M. Preston, John C. LaRosa,
cott M. Grundy, Prakash Deedwania, Heiner Greten, Nanette K. Wenger, James Shepherd,
avid D. Waters, John J. P. Kastelein, for the TNT Study Investigators
rsenault and colleagues investigated the utility of lipid and nonlipid biomarkers to predict
ajor cardiovascular events (MCVEs) in patients with stable coronary heart disease treated
ith a statin. This was a nested case-control study from the TNT (Treating to New Targets)
tudy. Fasting levels of standard lipids and of 18 nonlipid biomarkers were obtained after an
-week run-in period on atorvastatin 10 mg and again 1 year after being randomized to 10 or
0 mg atorvastatin. Low-density lipoprotein cholesterol, high-density lipoprotein cholesterol,
nd triglycerides were all predictive of recurrent MCVEs. While many of the 18 nonlipid
iomarkers were lowered by atorvastatin, they were not predictive of recurrent MCVEs.ARDIAC IMAGING70CMR Perfusion Imaging Correlates Well With FFRimothy Lockie, Masaki Ishida, Divaka Perera, Amedeo Chiribiri, Kalpa De Silva, Sebastian Kozerke,
ike Marber, Eike Nagel, Reza Razavi, Simon Redwood, Sven Plein
ockie and colleagues compared visual and quantitative analysis of high spatial resolution
ardiac magnetic resonance (CMR) myocardial perfusion imaging with invasively determined
ractional flow reserve (FFR). A total of 42 patients referred for angiography underwent
MR first; FFR was measured in all vessels with 50% severity stenosis. The sensitivity and
pecificity of visual CMR analysis to detect stenoses with an FFR 0.75 were 0.82 and 0.94.
igh-resolution CMR perfusion imaging may be useful for noninvasively detecting flow-imiting coronary artery disease.EDIATRIC CARDIOLOGY76Maternal Antiretroviral Therapy May Cause LV Thinning in HIV-Negative Infantsteven E. Lipshultz, William T. Shearer, Bruce Thompson, Kenneth C. Rich, Irene Cheng, E. John Orav,
ulekha Kumar, Ricardo H. Pignatelli, Louis I. Bezold, Philip LaRussa, Thomas J. Starc, Julie S. Glickstein,
haron O’Brien, Ellen R. Cooper, James D. Wilkinson, Tracie L. Miller, Steven D. Colan
ong-term cardiotoxicity after in utero exposure to antiretroviral therapy (ART) has been
escribed in animals. Lipshultz and colleagues investigated the possible effects of ART on
ardiac development and function in human immunodeficiency virus (HIV)-negative children
y comparing echocardiograms taken between birth and 24 months in HIV-negative infants
f HIV-positive mothers: those exposed to ART (ART) and unexposed infants (ART).
eptal wall thickness and left ventricular (LV) dimension were smaller than expected in
RT infants, but LV contractility was higher. Fetal exposure to ART is associated with
educed LV mass and may impair myocardial growth.(continued on page A-22)
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86oncoronary Cardiac Abnormalities Are Associated
With Coronary Artery Dilation in Acute Kawasaki Diseaseeth F. Printz, Lynn A. Sleeper, Jane W. Newburger, L. LuAnn Minich, Timothy Bradley, Meryl S. Cohen,
eborah Frank, Jennifer S. Li, Renee Margossian, Girish Shirali, Masato Takahashi, Steven D. Colan,
or the Pediatric Heart Network Investigators
rintz and colleagues explored the association of noncoronary cardiac abnormalities with
oronary artery dilation and inflammatory markers in patients with Kawasaki disease (KD).
t diagnosis, left ventricular systolic dysfunction was present in 20% of subjects and was
ssociated with coronary artery dilation. Mitral regurgitation was present in 27% and aortic
oot dilation in 8%; each was associated with larger coronary artery size. Noncoronary cardiac
bnormalities are associated with coronary artery dilation and laboratory evidence of
nflammation early in the course of KD.ARDIAC PHARMACOLOGY93Atorvastatin Prevents Nitrate Tolerance in Healthy Humansndrew Liuni, Mary Clare Luca, Giuseppe Di Stolfo, Amar Uxa, Justin A. Mariani, Tommaso Gori,
ohn D. Parker
nimal studies have demonstrated that statins can protect against nitroglycerin-induced
ndothelial dysfunction and tolerance. Liuni and colleagues studied endothelial function after
days of continuous transdermal nitroglycerin (GTN) in healthy subjects who were
andomized to placebo or atorvastatin. Acetylcholine responses in the GTN placebo group
ere significantly attenuated compared with the GTN atorvastatin group. These findings
emonstrate that atorvastatin prevents both GTN-induced endothelial dysfunction and nitrate
olerance.PRE-CLINICAL RESEARCH RE-CLINICAL RESEARCH
99dipokine Resistin Leads to Progression
of Atherosclerosis in a Rabbit Carotid ArteryAdhesion
Retention
Survival
Adventital
macrophagesoungjin Cho, Sang-Eun Lee, Hyun-Chae Lee, Jin Hur, Sahmin Lee, Seock-Won Youn, Jaewon Lee,
o-Jae Lee, Tae-Kyu Lee, Jonghanne Park, Seok-Jae Hwang, Yoo-Wook Kwon, Hyun-Jai Cho,
yung-Hee Oh, Young-Bae Park, Hyo-Soo Kim
ho and colleagues investigated the effects of human resistin on atherosclerotic progression in
rabbit model. Periadventitial resistin gene transfer induced macrophage infiltration and
xpression of various inflammatory cytokines, resulting in plaque growth and destabilization.
esistin also increased monocyte-endothelial cell adhesion, with effects on both monocytes
nd endothelial cells. Resistin aggravates atherosclerosis by stimulating monocytes, endothelial
ells, and vascular smooth muscle cells to induce vascular inflammation.
